Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxil
Open Access
- 16 February 2020
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 14 (4), 436-443
- https://doi.org/10.1111/irv.12728
Abstract
Background The novel cap‐dependent endonuclease inhibitor baloxavir marboxil was approved in February 2018 for the treatment of influenza virus infection in Japan. In vitro studies have revealed that an I38T substitution in the polymerase acidic subunit (PA) is associated with reduced susceptibility of influenza viruses to baloxavir. Objectives Development of a rapid and simple method for monitoring influenza A(H1N1)pdm09, A(H3N2), and B viruses possessing the I38T substitution in PA. Methods Three assays were developed based on RNase H2‐dependent PCR (rhPCR) and named A/H1pdm PA_I38T rhPCR, A/H3 PA_I38T rhPCR, and B PA_I38T rhPCR. The assays were evaluated using cDNAs synthesized from in vitro‐transcribed PA gene RNA controls, RNAs purified from viruses isolated in the 2017/2018 and 2018/2019 influenza seasons, and RNAs purified from clinical specimens collected in the 2018/2019 influenza season. Results The assays developed in this study accurately discriminated PA I38 and PA T38 with high sensitivity. Conclusions Our assays should be considered a powerful tool for monitoring the emergence of baloxavir‐resistant influenza viruses.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP18fk0108030)
- Ministry of Health, Labour and Welfare (10110400)
- Japan Society for the Promotion of Science (18K10036)
This publication has 23 references indexed in Scilit:
- Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxilInfluenza and Other Respiratory Viruses, 2020
- Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012–2018Antiviral Research, 2019
- Development of real‐time fluorescent reverse transcription loop‐mediated isothermal amplification assays for rhinovirus detectionJournal of Medical Virology, 2019
- Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018Eurosurveillance, 2019
- Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir MarboxilFrontiers in Microbiology, 2018
- Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxilScientific Reports, 2018
- Real-time RT-PCR assays for discriminating influenza B virus Yamagata and Victoria lineagesJournal of Virological Methods, 2014
- The Economic Burden of Non–Influenza-Related Viral Respiratory Tract Infection in the United StatesArchives of Internal Medicine, 2003
- Universal primer set for the full-length amplification of all influenza A virusesArchiv für die gesamte Virusforschung, 2001
- Generation of influenza A viruses entirely from cloned cDNAsProceedings of the National Academy of Sciences of the United States of America, 1999